Log In
BCIQ
Print this Print this
 

LPCN 1107

  Manage Alerts
Collapse Summary General Information
Company Lipocine Inc.
DescriptionOral hydroxyprogesterone caproate (HPC)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Genitourinary (unspecified)
Indication DetailsPrevent preterm birth; Prevent recurrent preterm birth
Regulatory Designation U.S. - Orphan Drug (Prevent preterm birth)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today